Not for a single one-day-early dose
If the patient has both obesity and type 2 diabetes, the provider may be able to prescribe Ozempic for the diabetes indication, and the patient may experience weight loss as a secondary benefit
Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) deliver effective glycaemic control with a low risk of hypoglycaemia, while increasing satiety, reducing body weight and blood pressure and improving cardiovascular disease (CVD) outcomes [35]
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study
Myth #12: Everyone Who Loses Weight Ends Up Worse Than Before The Claim: People lose weight then regain it all plus extra, ending up heavier and more metabolically damaged than when they started (Reddit r/antidiet post) The Reality: Weight cycling is concerning, but medication-assisted weight loss followed by maintenance (either through continued medication or lifestyle) doesnt lead to worse outcomes than never losing weight
What If I Experience Side Effects